Design of a modular protein-based MRI contrast agent for targeted application.

Magnetic resonance imaging (MRI) offers a non-radioactive alternative for the non-invasive detection of tumours. Low molecular weight MRI contrast agents currently in clinical use suffer either from a lack of specificity for tumour tissue or from low relaxivity and thus low contrast amplification. I...

Full description

Bibliographic Details
Main Authors: Daniel Grum, Stefan Franke, Oliver Kraff, Dominik Heider, Alexander Schramm, Daniel Hoffmann, Peter Bayer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3675113?pdf=render